Evidence map›Paper›PMID 42719545›Full record

ArticleFrontiers in pharmacology2026

Artificial intelligence-driven prediction and design of cell-penetrating peptides for advanced drug delivery system.

Bo Yu, Yue Lu, Zeying Kuang, Mengfan Zhao, Yi Quan, Hongyun Huang

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bo YuRheumatology and Immunology Department, Affiliated Hospital, Southwest Medical University, Luzhou, China.
Yue LuSichuan Treatment Center for Gynaecologic and Breast Diseases (Breast Surgery), Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Zeying KuangSichuan Treatment Center for Gynaecologic and Breast Diseases (Breast Surgery), Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Mengfan ZhaoSichuan Treatment Center for Gynaecologic and Breast Diseases (Breast Surgery), Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Yi QuanSichuan Treatment Center for Gynaecologic and Breast Diseases (Breast Surgery), Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Hongyun HuangSichuan Treatment Center for Gynaecologic and Breast Diseases (Breast Surgery), Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cell-penetrating peptides (CPPs) are promising delivery vectors for transporting therapeutic agents across cellular membranes. However, their rational design remains challenging because the relationship between peptide sequence and translocation efficiency is highly complex and nonlinear. Methods: In this study, we developed an artificial intelligence-driven framework that integrates biochemical rules derived from large language models (LLMs) with conventional peptide descriptors for CPP prediction and design. Interpretable rules extracted from GPT-4o and DeepSeek were encoded as binary feature vectors and combined with sequence-based descriptors to construct hybrid machine learning models. Model performance was evaluated on the benchmark CPP924 dataset using repeated stratified cross-validation, and the optimized models were further used for Results: The top-performing hybrid classifier achieved a cross-validated accuracy of 0.91 ± 0.03 (best single held-out split, 0.94) on the CPP924 dataset. The LLM-derived rules outperformed conventional physicochemical and fingerprint descriptors and matched amino-acid composition; integrating the rule and composition features yielded the best overall classifier. Using the optimized RF-GPT-Fre and RF-DS-Fre models, we generated six Conclusion: These findings demonstrate that combining LLM-derived biochemical knowledge with machine learning improves interpretable CPP prediction and candidate prioritisation. This study provides a reproducible computational strategy for peptide engineering and establishes a basis for the experimental evaluation of next-generation drug-delivery vehicles.

Indexed as

cell-penetrating peptides (CPPs)de novo peptide designdrug deliverylarge language models (LLMs)machine learning (ML)peptide delivery system

Identifiers

PMID42719545
PMCPMC13555210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.